Lanadelumab for Treatment of COVID-19 Disease
Clinical trial NCT04422509 · COMPLETED
Trial details
- NCT number
- NCT04422509
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2021-02-25
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.